Tie2-activating biologic therapeutic (Mannin Research/Q BioMed)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTie2-activating biologic therapeutic (Mannin Research/Q BioMed)
Drug Alias NameTie2-activating biologic therapeutic (Mannin Research/Q BioMed)MAN-12
ClassificationBiologics
Mechanisms of ActionTEK receptor tyrosine kinase agonists
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsRenal InsufficiencyGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMannin Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQ Biomed IncMannin Research Inc
Active IndicationsN/A
Inactive IndicationsRenal InsufficiencyGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A